COMMUNIQUÉS West-GlobeNewswire

Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA® (Tesamorelin for Injection) for FDA Approval
04/07/2018
MONTREAL, July 04, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that it has filed a supplemental new drug application (sNDA) with the Food and Drug Administration (FDA) [...]
Theratechnologies soumet à la FDA une nouvelle formulation d’EGRIFTA(MD) (tésamoréline pour injection) en fiole unique
04/07/2018
MONTRÉAL, 04 juill. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) a annoncé aujourd’hui qu’elle a déposé un supplemental new drug application (sNDA) auprès de la Food and Drug [...]
VitalHub Announces Results of June 2018 AGM
04/07/2018
TORONTO, July 04, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) is pleased announce the results of June 2018 Annual General Meeting (“AGM”), and recent proceeds to the Company derived [...]
CORRECTION FIT Biotech Oy: FIT Biotech's company site has been launched in Inderes.fi
04/07/2018
FIT Biotech Oy Press Release July 4 th , 2018, 12.30 EET FIT Biotech's company site has been launched in Inderes.fi FIT Biotech's company site has been launched at the Inderes.fi-service: https://www.inderes.fi/yhtiot/ [...]
Solon Eiendom ASA : Primary insider notification
04/07/2018
(Oslo, Norway, July 4, 2018) UFI AS has today bought 19 791 shares in Solon Eiendom ASA at a price of NOK 30.06 per share. Solon Eiendom ASA Board Member Øystein A. Landvik owns 33,34 % of the shares in UFI AS. [...]
FIT Biotech Oy: FIT Biotech's company site has been launched in Inderes.fi
04/07/2018
FIT Biotech Oy Press Release July 4 th , 2018, 09.30 EET FIT Biotech's company site has been launched in Inderes.fi FIT Biotech's company site has been launched at the Inderes.fi-service: https://www.inderes.fi/yhtiot/ [...]
Shire plc : Rule 2.9 Announcement
04/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 4 July 2018 Shire [...]
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/07/2018
BURLINGTON, Mass., July 03, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to nine new employees for an aggregate of 30,700 shares of common stock. [...]
BeiGene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
03/07/2018
CAMBRIDGE, Mass., and BEIJING, China, July 03, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted [...]
GBT Announces New Employment Inducement Grants
03/07/2018
SOUTH SAN FRANCISCO, Calif., July 03, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that, on July 2, 2018, the compensation committee of the Company’s board of directors [...]
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
03/07/2018
WAYNE, Pa., July 03, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated [...]
Cue Health Receives ISO 13485 Certification
03/07/2018
SAN DIEGO, July 03, 2018 (GLOBE NEWSWIRE) -- Cue Health Inc. (“Cue”), a healthcare technology company developing a connected diagnostics platform for professionals and consumers, today announced that it received its ISO [...]
AB Science : Résultats de l'Assemblée Générale Mixte du 29 juin 2018
03/07/2018
Paris, 3 juillet 2018 Résultats de l'Assemblée Générale Mixte du 29 juin 2018 Les actionnaires de la société AB Science se sont réunis en Assemblée Générale Mixte, le vendredi 29 juin 2018, à 16 heures 00 au cabinet d' [...]
AB Science situation and future prospects presented during the Combined General Shareholders' Meeting held on July 29 2018
03/07/2018
Paris, July 3, 2018, 6.30pm Results of the June 29, 2018 Combined General Shareholders' Meeting A Combined General Shareholders' Meeting was held on July 29, 2018 in Paris. The shareholders present or represented [...]
AB Science : Situation et les perspectives de l'entreprise présentées lors de l'Assemblée Générale Mixte du 29 juillet 2018
03/07/2018
Paris, 3 juillet 2018, 18h30 Résultats de l'Assemblée Générale Mixte du 29 juin 2018 Les actionnaires de la société AB Science se sont réunis en Assemblée Générale Mixte, le vendredi 29 juillet 2018 à Paris. Les [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
03/07/2018
Company Announcement Copenhagen, Denmark; July 3, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 24,025 shares as a consequence of the exercise of employee warrants. The increase is [...]
EUROBIO SCIENTIFIC : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONCLU AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONT
03/07/2018
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ D'EUROBIO SCIENTIFIC CONCLU AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONT Paris, le 3 juillet 2018 - 17h45 Au titre du contrat de liquidité confié à la Société de Bourse Gilbert [...]
Agility Health Reports First Quarter 2018 Financial Results
03/07/2018
HAMILTON, Ontario, July 03, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV:AHI) (“ Agility Health ” or “ Corporation ”), a leading provider of orthotics, prosthetics and foot care services in Canada, today reported [...]
Sorrento Acquires the Sofusa™ Lymphatic Delivery Platform for Immune-Oncology (I-O) Antibody Therapeutics
03/07/2018
SAN DIEGO, July 03, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) ("Sorrento") announced today that it acquired the Sofusa™ lymphatic delivery technology platform from Kimberly-Clark Corporation for [...]

Pages